Project team
Our Team
University of Sussex Business School
Brighton and Sussex Medical School
University of Cambridge
University of Oxford
Partners
INGENIO UPV (Spain)
CIRCA (Ireland)
Ansbach University of Applied Sciences (Germany)
Professor Michael Hopkins (Principal Investigator)
Professor at the Science Policy Research Unit – SPRU.
Michael is a biologist with subsequent degrees in Technology and Innovation Management (M. Sc. with Distinction), and Science and Technology Policy (D.Phil). He has more than 20 years’ experience researching the sociotechnical challenges associated with medical innovation in products, services and systems for diagnostic testing. In recent years Michael has led a series of international research projects studying different aspects of the innovation ecosystems that support medical innovation, particularly in pharmaceuticals and diagnostics, although not exclusively.
Dr Choon Key Chekar
Senior Research Associate
Choon Key has more than 10 years’ experience of cross-national comparative research on the lived experience of recent innovations in medicine, including, genomic cancer medicine and the stem cell industry in East and South Asia.
Senior Lecturer in Sexual Health and HIV Medicine and an Honorary Consultant Physician at the Brighton and Sussex University Hospitals.
Collins obtained his medical degree from the Faculty of Medicine, Abia State University, Nigeria, followed by training in general internal in Birmingham. He completed his Specialist training in Sexual Health and HIV Medicine in 2011. Collins has an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine, University of London. Collins has been involved in Global Health research in HIV since 2011 and has broad research interests on HIV treatment outcomes in resource-constrained settings and sexually transmitted infections.
Research Fellow at the Science Policy Research Unit.
Joshua has five years’ experience researching research systems and scientific knowledge for epidemic response. His main research focus is knowledge dynamics and global health emergencies. His MSc dissertation was entitled "Funding Biodefense: Gaps in the fence?" Joshua's PhD focussed on the learning from pandemics and was titled "knowledge accumulation in disease outbreak response." His current work explores novel methods for evaluating research and learning lessons from international Covid-19 testing systems.
Professor Gail Davey is a Professor of Global Health Epidemiology.
Gail is a medical epidemiologist specialising in skin-related Neglected Tropical Diseases in low
resource settings. Following training in epidemiology at Master and doctoral level at the London School of Hygiene & Tropical Medicine, Davey moved to Ethiopia to work with national colleagues in the School of Public Health, Addis Ababa University. There, she initiated a multidisciplinary program of research into podoconiosis (endemic nonfilarial elephantiasis). On returning to the UK, she has continued to expand podoconiosis research within Ethiopia and into other endemic countries.
Professor in Infectious Diseases
Prof Martin Llewelyn has 16 years’ research experience and 28 years’ clinical practice
experience and is a Fellow of the Royal College of Physicians. He undertook higher specialist training in Infectious Diseases and General Internal Medicine in North Thames. Martin’s research is focused on the common, life-threatening infections which affect patients in the NHS, in particular on healthcare associated and antibiotic resistant pathogens such as Staphylococcus aureus and Clostridium difficile.
Lecturer in Sociology of Science and Technology.
Stuart’s work focuses on biomedical innovation and his research has investigated a diverse range of emergent biotechnologies, such as stem cell therapies and synthetic biology. An expert on diagnostics policy, in particular regulatory policy, he has conducted hundreds of interviews with senior figures in industry, regulatory bodies and biomedical science. His work is situated at the interface of science and technology studies, medical sociology, history of medicine, bioethics, innovation studies and regulatory studies.
Research Associate at the Department of Sociology
Olga has expertise in the politics of health policy and the study of how different health systems adopt internationally popular policy solutions (e.g. health technology assessment). She has presented and discussed her research with policy-makers from the European Union, Czechia, and Lithuania. For the past three years, she has been working on the regulation of diagnostics in Europe on the CancerScreen project. She also has past experience as a consultant in European and global health policy, and in Brussels pharmaceutical lobbying.
Professor of Microbiology
Professor Crook is also an NHS consultant in infectious diseases, clinical microbiology and academic molecular microbiologist with extensive experience leading large-scale data science
and pathogen-whole-genome-sequencing (WGS) projects. Crook has played a leading role in
treatment of and research on hospital acquired and community acquired infectious diseases.
Associate Professor of Innovation Management in INGENIO (CSICUPV),Technical University of València (Spain).
David has over 10 years’ experience researching innovation in medical devices. Prior to his academic career, he spent seven years as a R&D Project Manager in a Spanish medical technology company, where he leaded numerous R&D Projects. Part of the results of those projects was reflected in three European Patents, where he figures as inventor with other researchers. He has participated in several projects about medical innovation and led a research contract with a Spanish Centre of Research on Rare Diseases for analysing rare diseases policies in five European countries.
In my professional career I have 25 years experience as a manager in a private company within the Health Technologies sector. I oversaw 95 employees across 23 work centers. More recently I have worked as a European Funding Project Manager in a R&D Consultancy company. In addition I come from an academic/research background in the area of Social Sciences and Innovation Management (specially in medical innovation).
Consultant
Dr Jim Ryan B.Sc., Ph.D. is an experienced specialist in science policy and innovation management with emphasis on life sciences. He is a full-time consultant with CIRCA, and has worked extensively as a consultant on projects in Europe, Middle East, Thailand, Malaysia, China and Azerbaijan. He has also represented Ireland on many international committees. Past employments include 6 years as
director of BioResearch Ireland (Ireland’s National Biotechnology Programme) with responsibility for developing biotechnology strategy and for commercialising university research.
Professor for Biotechnology and Bioethics.
Sibylle She has more than 25 years of experience in technology assessment, innovation studies and strategic analysis of the uptake, dissemination and perception of new technologies. Major research projects were the development of an assessment tool for sustainable drug supply, the development of a roadmap for synthetic biology in Europe and more recently, the analysis of communication effects on the perception of new biomedical developments
Mr Alexander Ghionis
Doctoral Researcher
Alexander is a Doctoral Researcher in the Harvard Sussex Program. His research looks at change and continuity in the Organisation for the Prohibition of Chemical Weapons (OPCW), with particular interest in the cultures and identities of its Technical Secretariat. He has a Master's Degree in Geopolitics and Grand Strategy from the University of Sussex.